Bausch + Lomb Enters Licensing Agreement With Intraocular Lens Design Group Tatvum Research
October 01, 2019
October 01, 2019
ROCHESTER, New York, Oct. 1 -- Bausch + Lomb issued the following news release:
Bausch + Lomb, a leading global eye health company, today announced that it has entered into a licensing agreement with Tatvum Research, a company focused on intraocular lens (IOL) development and design. The agreement provides Bausch + Lomb with worldwide commercial rights to new IOL designs for enVista(R) IOLs that will address astigmatism and presbyopia.
"This agreement is part of ou . . .
Bausch + Lomb, a leading global eye health company, today announced that it has entered into a licensing agreement with Tatvum Research, a company focused on intraocular lens (IOL) development and design. The agreement provides Bausch + Lomb with worldwide commercial rights to new IOL designs for enVista(R) IOLs that will address astigmatism and presbyopia.
"This agreement is part of ou . . .